A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : sFasL

Search Conditions:
Search Keyword : sFasL
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: sFasL
Appearance Frequency: 336 time(s)
Long forms: 19

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
soluble Fas ligand
(203 times)
Allergy and Immunology
(34 times)
sFas (59 times)
mFasL (19 times)
ELISA (16 times)
1997 Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
soluble FasL
(86 times)
Allergy and Immunology
(18 times)
FasL (59 times)
sFas (16 times)
mFasL (5 times)
1996 An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand.
sFas ligand
(12 times)
Pulmonary Medicine
(2 times)
sFas (10 times)
AST (1 time)
BALF (1 time)
2004 Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.
soluble form of FasL
(11 times)
Allergy and Immunology
(3 times)
FasL (7 times)
mFasL (3 times)
PBMC (2 times)
1997 Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
soluble form of Fas ligand
(5 times)
Cardiology
(2 times)
AMI (2 times)
AP (1 time)
FasL (1 time)
1998 Chemotactic activity of soluble Fas ligand against phagocytes.
sFas and sFas ligand
(3 times)
Science
(1 time)
ELISA (1 time)
LV (1 time)
MMP (1 time)
2001 Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
plasma-soluble Fas ligand
(2 times)
Hematology
(1 time)
AMD (1 time)
ELISA (1 time)
HCV (1 time)
2000 Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C.
soluble Fas ligand levels
(2 times)
Transplantation
(1 time)
AR (1 time)
FasL (1 time)
mFas (1 time)
1999 Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis.
soluble FasL fragment
(2 times)
Neoplasms
(1 time)
FasL (1 time)
mFasL (1 time)
OSCC (1 time)
2016 Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.
10  secreted FasL
(1 time)
Science
(1 time)
FasL (1 time)
mFasL (1 time)
SLE (1 time)
2009 Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
11  serum-soluble FasL
(1 time)
Hematology
(1 time)
IFN-gamma (1 time)
IL-1beta (1 time)
IL-2 (1 time)
2000 Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity.
12  sFas, Fas ligand
(1 time)
Neurology
(1 time)
MS (1 time)
sTRAIL (1 time)
2010 Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?
13  shed FasL
(1 time)
Chemistry
(1 time)
mFasL (1 time)
MMPs (1 time)
2008 FasL shedding is reduced by hypothermia in experimental stroke.
14  shedding of FasL
(1 time)
Pediatrics
(1 time)
MOF (1 time)
sFas (1 time)
SIRS (1 time)
2002 sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
15  soluble Fas and its ligand
(1 time)
Gynecology
(1 time)
IUGR (1 time)
2005 Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.
16  soluble form of human FasL
(1 time)
Biotechnology
(1 time)
FasL (1 time)
TNF (1 time)
1995 Expression of the functional soluble form of human fas ligand in activated lymphocytes.
17  soluble homotrimeric FasL
(1 time)
Hematology
(1 time)
AML (1 time)
FasL (1 time)
IL-2 (1 time)
2005 CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia.
18  soluble ligand for the Fas receptor
(1 time)
Cell Biology
(1 time)
sFas (1 time)
2005 Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
19  soluble recombinant human FasL
(1 time)
Transplantation
(1 time)
CrmA (1 time)
FasL (1 time)
MOI (1 time)
2001 In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.